Cargando…

Development and Research Progress of Anti-Drug Resistant Bacteria Drugs

Bacterial resistance has become increasingly serious because of the widespread use and abuse of antibiotics. In particular, the emergence of multidrug-resistant bacteria has posed a serious threat to human public health and attracted the attention of the World Health Organization (WHO) and the gover...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Xiangyi, Lü, Yuhong, Yue, Changwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711564/
https://www.ncbi.nlm.nih.gov/pubmed/34992385
http://dx.doi.org/10.2147/IDR.S338987
_version_ 1784623396087136256
author Cui, Xiangyi
Lü, Yuhong
Yue, Changwu
author_facet Cui, Xiangyi
Lü, Yuhong
Yue, Changwu
author_sort Cui, Xiangyi
collection PubMed
description Bacterial resistance has become increasingly serious because of the widespread use and abuse of antibiotics. In particular, the emergence of multidrug-resistant bacteria has posed a serious threat to human public health and attracted the attention of the World Health Organization (WHO) and the governments of various countries. Therefore, the establishment of measures against bacterial resistance and the discovery of new antibacterial drugs are increasingly urgent to better contain the emergence of bacterial resistance and provide a reference for the development of new antibacterial drugs. In this review, we discuss some antibiotic drugs that have been approved for clinical use and a partial summary of the meaningful research results of anti-drug resistant bacterial drugs in different fields, including the antibiotic drugs approved by the FDA from 2015 to 2020, the potential drugs against drug-resistant bacteria, the new molecules synthesized by chemical modification, combination therapy, drug repurposing, immunotherapy and other therapies.
format Online
Article
Text
id pubmed-8711564
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87115642022-01-05 Development and Research Progress of Anti-Drug Resistant Bacteria Drugs Cui, Xiangyi Lü, Yuhong Yue, Changwu Infect Drug Resist Review Bacterial resistance has become increasingly serious because of the widespread use and abuse of antibiotics. In particular, the emergence of multidrug-resistant bacteria has posed a serious threat to human public health and attracted the attention of the World Health Organization (WHO) and the governments of various countries. Therefore, the establishment of measures against bacterial resistance and the discovery of new antibacterial drugs are increasingly urgent to better contain the emergence of bacterial resistance and provide a reference for the development of new antibacterial drugs. In this review, we discuss some antibiotic drugs that have been approved for clinical use and a partial summary of the meaningful research results of anti-drug resistant bacterial drugs in different fields, including the antibiotic drugs approved by the FDA from 2015 to 2020, the potential drugs against drug-resistant bacteria, the new molecules synthesized by chemical modification, combination therapy, drug repurposing, immunotherapy and other therapies. Dove 2021-12-21 /pmc/articles/PMC8711564/ /pubmed/34992385 http://dx.doi.org/10.2147/IDR.S338987 Text en © 2021 Cui et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Cui, Xiangyi
Lü, Yuhong
Yue, Changwu
Development and Research Progress of Anti-Drug Resistant Bacteria Drugs
title Development and Research Progress of Anti-Drug Resistant Bacteria Drugs
title_full Development and Research Progress of Anti-Drug Resistant Bacteria Drugs
title_fullStr Development and Research Progress of Anti-Drug Resistant Bacteria Drugs
title_full_unstemmed Development and Research Progress of Anti-Drug Resistant Bacteria Drugs
title_short Development and Research Progress of Anti-Drug Resistant Bacteria Drugs
title_sort development and research progress of anti-drug resistant bacteria drugs
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711564/
https://www.ncbi.nlm.nih.gov/pubmed/34992385
http://dx.doi.org/10.2147/IDR.S338987
work_keys_str_mv AT cuixiangyi developmentandresearchprogressofantidrugresistantbacteriadrugs
AT luyuhong developmentandresearchprogressofantidrugresistantbacteriadrugs
AT yuechangwu developmentandresearchprogressofantidrugresistantbacteriadrugs